Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.6, Iss.10, 2010-10, pp. : 1287-1300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antifungal peptides: potential candidates for the treatment of fungal infections

By de Lucca A.J.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 2, 2000-02 ,pp. : 273-299

Informa Healthcare

Access to resources Recommend Favorite

Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections

By Lestner Jodi

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 7, 2013-07 ,pp. : 911-926

Informa Healthcare

Access to resources Recommend Favorite

Achieving an Optimal Outcome in the Treatment of Infections: The Role of Clinical Pharmacokinetics and Pharmacodynamics of Antimicrobials

By Li R.C.

Clinical Pharmacokinetics, Vol. 37, Iss. 1, 1999-07 ,pp. : 1-16

Adis International

Access to resources Recommend Favorite

Anidulafungin: an echinocandin antifungal

By Pfaller Michael A

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1183-1197

Informa Healthcare

Access to resources Recommend Favorite

Echinocandin Antifungal Drugs in Fungal Infections: A Comparison

By Chen Sharon C.-A.

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 11-41

Adis International

Access to resources Recommend Favorite